Evidence map›Paper›PMID 37407817›Full record

ArticleNature2023

Hepatitis C virus RNA is 5'-capped with flavin adenine dinucleotide.

Anna V Sherwood, Lizandro R Rivera-Rangel, Line A Ryberg, Helena S Larsen, Klara M Anker, Rui Costa, Cathrine B Vågbø, Eva Jakljevič, Long V Pham, Carlota Fernandez-Antunez and 18 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. RNA regulation in plants.Science China. Life sciences · 2026
    Review
  4. Article
  5. Molecular insight into 5' RNA capping with NpNature chemical biology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 2 institutions in 3 countries.

Anna V Sherwood *Section for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0001-7153-8420
Lizandro R Rivera-Rangel *Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Line A RybergCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Helena S LarsenCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Klara M AnkerSection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0002-2459-8583
Rui CostaCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0003-3048-6366
Cathrine B VågbøProteomics and Modomics Experimental Core (PROMEC), Norwegian University of Science and Technology and the Central Norway Regional Health Authority, Trondheim, Norway.
Eva JakljevičCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0003-3657-1254
Long V PhamCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Carlota Fernandez-AntunezCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Gabriele IndrisiunaiteSection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
Agnieszka Podolska-CharlerySection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0003-3789-2746
Julius E R GrothenSection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0002-1857-6134
Nicklas W LangvadSection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0002-9980-5030
Nicolas FossatCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0002-0161-6507
Anna OffersgaardCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0002-7748-2840
Amal Al-ChaerSection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
Louise NielsenCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Anna KuśnierczykProteomics and Modomics Experimental Core (PROMEC), Norwegian University of Science and Technology and the Central Norway Regional Health Authority, Trondheim, Norway.ORCID 0000-0003-3517-3481
Christina SølundDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Nina WeisDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0002-3133-2724
Judith M GottweinCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0003-2805-0256
Kenn HolmbeckCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.
Sandro BottaroSection for Biomolecular Sciences, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID 0000-0003-1606-890X
Santseharay RamirezCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark.ORCID 0000-0003-3699-1814
Jens BukhCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark. jbukh@sund.ku.dk.ORCID 0000-0002-7815-4806
Troels K H ScheelCopenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark. tscheel@sund.ku.dk.ORCID 0000-0003-1545-4067
Jeppe VintherSection for Computational and RNA Biology, Department of Biology, University of Copenhagen, Copenhagen N, Denmark. jvinther@bio.ku.dk.ORCID 0000-0002-3847-3853
University of Copenhagen · DKNorwegian University of Science and Technology · NO

Funding

European Research Council 802899
6 · The paper itself

Abstract

RNA viruses have evolved elaborate strategies to protect their genomes, including 5' capping. However, until now no RNA 5' cap has been identified for hepatitis C virus

Indexed as

Flavin-Adenine DinucleotideHepacivirusRNA CapsRNA, ViralAnimalsChimeraDEAD Box Protein 58Hepatitis CHumansInnate Immunity RecognitionLiverMiceReceptors, ImmunologicRNA-Dependent RNA PolymeraseRNA StabilityVirus ReplicationDEAD Box Protein 58Flavin-Adenine DinucleotideReceptors, ImmunologicRIGI protein, humanRNA CapsRNA-Dependent RNA PolymeraseRNA, Viral

Identifiers

PMID37407817
PMCPMC7616780
OpenAlexW4383265623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.